Aimei Health Technology (NASDAQ:AFJK) Share Price Breaks Above 50-Day Moving Average – Time to Sell?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK)’s stock price passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $12.22 and traded as high as $12.75. Aimei Health Technology shares last traded at $12.43, with a volume of 10,748 shares traded.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Wall Street Zen raised Aimei Health Technology to a “sell” rating in a research note on Saturday, September 19th. Weiss Ratings cut shares of Aimei Health Technology from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, August 21st. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Aimei Health Technology presently has a consensus rating of “Sell”.

Aimei Health Technology Stock Up 3.3%

The company’s fifty day moving average price is $12.22 and its 200-day moving average price is $26.59. The stock has a market capitalization of $39.40 million, a PE ratio of 207.20 and a beta of 0.97.

Aimei Health Technology (NASDAQ:AFJK) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.03) earnings per share for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

A hedge fund recently bought a new stake in Aimei Health Technology stock. First Trust Capital Management L.P. bought a new position in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 677,008 shares of the company’s stock, valued at approximately $8,199,000. First Trust Capital Management L.P. owned approximately 21.38% of Aimei Health Technology as of its most recent filing with the Securities and Exchange Commission (SEC). 45.58% of the stock is owned by institutional investors.

About Aimei Health Technology

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.